Evidence map›Paper›PMID 37580258›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Improvement situation on indexes of the zebrafish disease model of non-alcoholic fatty liver disease with FGF21 analogues].

X X Mi, J Yan, J P Shi

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. [Liver-bone axis: novel mechanisms and strategies for MAFLD regulation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

X X MiCentre for Translational Medicine, Hangzhou Normal University Affiliated Hospital, Hangzhou 310015, China.
J YanCentre for Translational Medicine, Hangzhou Normal University Affiliated Hospital, Hangzhou 310015, China.
J P ShiCentre for Translational Medicine, Hangzhou Normal University Affiliated Hospital, Hangzhou 310015, China.
Affiliated Hospital of Hangzhou Normal University · CN

Funding

National Natural Science Foundation of China 82100614The Joint Funds of the Zhejiang Provincial Natural Science Foundation of China LBY21H030001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Non-alcoholic Fatty Liver DiseaseZebrafish ProteinsAnimalsBody WeightDiet, High-FatFibroblast Growth FactorsLipidsLiverTriglyceridesZebrafishfibroblast growth factor 21Fibroblast Growth FactorsLipidsTriglyceridesZebrafish ProteinsDiseaseIndicationsNon-alcoholic fatty liver diseaseZebrafish

Identifiers

PMID37580258
PMCPMC12814000
OpenAlexW4385827350

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.